Victor J. Dzau M.D.
Senior Advisor,Kearny Venture Partners
|Age||Total Calculated Compensation||This person is connected to 87 board members in 5 different organizations across 14 different industries.|
See Board Relationships
Dr. Victor J. Dzau, M.D., has been President of The Institute of Medicine at National Academy of Sciences since February 2014. Dr. Dzau serves as Senior Advisor at Kearny Venture Partners. He has been the Senior Scientific Advisor of Chondrogene Ltd. since January 2004. He was a Co-Founder of Clingenix, Inc. He has served as a Scientific Advisor to Novartis, Merck, Bristol Meyers Squibb and other pharmaceutical companies. Dr. Dzau was the Chancellor of Health Affairs, ...
One Maritime PlazaPhone: 415-875-7777
San Francisco, California 94111
Board Members Memberships*
Board Member and Member of Research Committee
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
|There is no Competitor Compensation data available.|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.